Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Assets |
| Cash and equivalents | 17.0 | 25.0 | 85.4 | 31.7 | 41.7 | 62.5 | 15.0 | 12.3 |
| Other current assets | 43.2 | 75.2 | 6.6 | 6.4 | 2.5 | 3.0 | 2.4 | 0.4 |
| Total current assets | 60.2 | 100.2 | 92.1 | 38.2 | 44.2 | 65.5 | 17.4 | 12.7 |
| Property, plant, and equipment, net | 1.6 | 2.4 | 4.1 | 5.1 | 2.7 | 1.4 | 0.4 | 0.1 |
| Other fixed assets | 0.2 | 0.0 | 0.2 | 0.1 | 0.0 | 0.0 | | |
| Total assets | 66.3 | 107.7 | 102.3 | 49.1 | 47.0 | 67.0 | 17.9 | 12.9 |
| |
| Accounts payable | 2.2 | 1.8 | 7.4 | 11.1 | 6.3 | 3.1 | 3.4 | 1.3 |
| Accrued expenses | 2.2 | 2.7 | 4.2 | 22.4 | 9.9 | 4.7 | 3.3 | 0.6 |
| Short-term debt | 2.8 | 3.1 | 0.7 | 0.8 | 0.4 | 0.3 | 0.3 | 0.2 |
| Short-term debt | 2.8 | 3.1 | 0.7 | 0.8 | 0.4 | 0.3 | 0.3 | 0.2 |
| Deferred revenues | | | | | 1.5 | | 1.9 | 1.6 |
| Other current liabilities | 5.4 | 9.4 | 19.6 | 0.6 | 0.0 | | 0.0 | |
| Total current liabilities | 12.6 | 17.0 | 31.9 | 34.9 | 18.1 | 8.2 | 8.9 | 3.6 |
| Long-term debt | | | | | | | | 0.2 |
| Other liabilities | 20.7 | 21.6 | 25.1 | 8.1 | 1.4 | 1.0 | 0.1 | 0.1 |
| Total liabilities | 33.3 | 38.6 | 57.0 | 43.0 | 19.5 | 9.2 | 9.0 | 3.9 |
| |
| Shareholders' equity [+] | 33.0 | 69.1 | 45.3 | 6.2 | 27.5 | 57.8 | 8.9 | 9.0 |
| Paid-in capital | 425.2 | 418.9 | 349.4 | 199.0 | 148.9 | 123.5 | 42.2 | 22.3 |
| Retained earnings | -392.1 | -349.7 | -304.1 | -192.8 | -121.4 | -65.7 | -33.3 | -13.3 |
| Tangible shareholders' equity | 33.0 | 69.1 | 45.3 | 6.2 | 27.5 | 57.8 | 8.9 | 9.0 |
|